Trency Gu, PhDManaging Director at Sequoia Capital
Trency Gu, Managing Director at Sequoia China, focusing on healthcare investment, esp. on innovative therapeutics, molecular diagnostics and precision medicine. Prior to joining Sequoia in 2012, she worked as an Associate at OrbiMed Asia team, focusing on healthcare investment, including pharma, biotech and medical devices. Prior to joining OrbiMed, Dr. Gu worked as a Project Manager at Eli Lilly Global External Research and Development Department in Shanghai, where she was involved in the collaborations and partnering activities. Prior, she was a Director for Development Planning at Shanghai Genomics, a biotech company focused on drug discovery and development. There, she managed in-licensing activities and IND-enabling studies for NCE development. Dr. Gu has a B.S. with double majors in Biotechnology and English, and a Ph.D. in Biochemistry and Molecular Biology, both from Shanghai Jiao Tong University.